SCH00013, a novel Ca2+ sensitizer with positive inotropic and no chronotropic action in heart failure

8Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

We investigated the effects of the agent SCH00013 on Ca2+- induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The Ca 2+-induced force generation in skinned cardiac muscle fibers was determined at pH 6.2-7.4, and SCH00013 was found to have a significant Ca 2+ sensitizing effect at pH 7.2 to 7.4. There was no significant difference in the Ca2+ sensitizing action between the enantiomers of SCH00013. The Ca2+ sensitizing effect of SCH00013 was dependent on the sarcomere length, being significant only at a long sarcomere length. SCH00013 elicited a positive inotropic effect at more than 0.3 and 1 mg/kg, i.v. in normal and heart failure dogs, respectively, with no chronotropic action. These results strongly suggested that SCH00013 is a novel Ca2+ sensitizer that elicits a positive inotropic and no chronotropic effect in heart failure, probably through enhancing the Frank-Starling mechanism. © 2005 The Japanese Pharmacological Society.

Cite

CITATION STYLE

APA

Tadano, N., Morimoto, S., Yoshimura, A., Miura, M., Yoshioka, K., Sakato, M., … Sasaguri, T. (2005). SCH00013, a novel Ca2+ sensitizer with positive inotropic and no chronotropic action in heart failure. Journal of Pharmacological Sciences, 97(1), 53–60. https://doi.org/10.1254/jphs.FP0040654

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free